Abstract
The paracaspase MALT1 is essential for the activation of NF-κB in response to T cell receptor (TCR) stimulation. It recruits downstream TRAF6 and activates the E3 ligase activity of TRAF6 to polyubiquitinate several targets, which ultimately leads to NF-κB activation. Here we identified ubiquitin-specific protease 2a (USP2a) as a MALT1-associated protein by biochemical affinity purification. Endogenous USP2a constitutively interacted with TRAF6, but dynamically interacted with MALT1 and CARMA1 in a stimulation-dependent manner. RNA interference (RNAi)-mediated silencing of USP2a attenuated TCR-induced NF-κB activation and production of interleukin-2 (IL-2). In addition, the ubiquitination of MALT1 and TRAF6 were both suppressed by USP2a knockdown. By knockdown and reconstitution assays, we found that USP2a mediated the interaction between MALT1 and TRAF6 in a catalytic activity-dependent manner. Furthermore, USP2a deSUMOylated TRAF6. Our findings implicate that USP2a plays an important role in TCR signaling by deSUMOylating TRAF6 and mediating TRAF6-MALT1 interaction.
Article PDF
Similar content being viewed by others
References
Alberola-Ila, J., Takaki, S., Kerner, J.D., and Perlmutter, R.M. (1997). Differential signaling by lymphocyte antigen receptors. Annu Rev Immunol 15, 125–154.
Bergink, S., and Jentsch, S. (2009). Principles of ubiquitin and SUMO modifications in DNA repair. Nature 458, 461–467.
Coornaert, B., Baens, M., Heyninck, K., Bekaert, T., Haegman, M., Staal, J., Sun, L., Chen, Z.J., Marynen, P., and Beyaert, R. (2008). T cell antigen receptor stimulation induces MALT1 paracaspase-mediated cleavage of the NF-kappaB inhibitor A20. Nat Immunol 9, 263–271.
Deng, L., Wang, C., Spencer, E., Yang, L., Braun, A., You, J., Slaughter, C., Pickart, C., and Chen, Z.J. (2000). Activation of the IkappaB kinase complex by TRAF6 requires a dimeric ubiquitin-conjugating enzyme complex and a unique polyubiquitin chain. Cell 103, 351–361.
Gaide, O., Favier, B., Legler, D.F., Bonnet, D., Brissoni, B., Valitutti, S., Bron, C., Tschopp, J., and Thome, M. (2002). CARMA1 is a critical lipid raft-associated regulator of TCR-induced NF-kappa B activation. Nat Immunol 3, 836–843.
Ghosh, S., May, M.J., and Kopp, E.B. (1998). NF-kappa B and Rel proteins: evolutionarily conserved mediators of immune responses. Annu Rev Immunol 16, 225–260.
Hannoun, Z., Greenhough, S., Jaffray, E., Hay, R.T., and Hay, D.C. (2010). Post-translational modification by SUMO. Toxicology 278, 288–293.
He, X., Li, Y., Li, C., Liu, L.J., Zhang, X.D., Liu, Y., and Shu, H.B. (2012). USP2a negatively regulates IL-1beta- and virus-induced NF-kappa B activation by deubiquitinating TRAF6. J Mol Cell Biol. (In Press).
Li, Y., Chen, R., Zhou, Q., Xu, Z., Li, C., Wang, S., Mao, A., Zhang, X., He, W., and Shu, H.B. (2012). LSm14A is a processing body-associated sensor of viral nucleic acids that initiates cellular antiviral response in the early phase of viral infection. Proc Natl Acad Sci U S A 109, 11770–11775.
Liu, Y., Song, R., Gao, Y., Li, Y., Wang, S., Liu, H.Y., Wang, Y., Hu, Y.H., and Shu, H.B. (2012). Protein kinase C-delta negatively regulates T cell receptor-induced NF-kappaB activation by inhibiting the assembly of CARMA1 signalosome. J Biol Chem 287, 20081–20087.
Mahul-Mellier, A.L., Pazarentzos, E., Datler, C., Iwasawa, R., AbuAli, G., Lin, B., and Grimm, S. (2012). De-ubiquitinating protease USP2a targets RIP1 and TRAF2 to mediate cell death by TNF. Cell Death Differ 19, 891–899.
Metzig, M., Nickles, D., Falschlehner, C., Lehmann-Koch, J., Straub, B.K., Roth, W., and Boutros, M. (2011). An RNAi screen identifies USP2 as a factor required for TNF-alpha-induced NF-kappaB signaling. Int J Cancer 129, 607–618.
Oeckinghaus, A., Wegener, E., Welteke, V., Ferch, U., Arslan, S.C., Ruland, J., Scheidereit, C., and Krappmann, D. (2007). Malt1 ubiquitination triggers NF-kappaB signaling upon T-cell activation. EMBO J 26, 4634–4645.
Oh, K.H., Yang, S.W., Park, J.M., Seol, J.H., Iemura, S., Natsume, T., Murata, S., Tanaka, K., Jeon, Y.J., and Chung, C.H. (2011). Control of AIF-mediated cell death by antagonistic functions of CHIP ubiquitin E3 ligase and USP2 deubiquitinating enzyme. Cell Death Differ 18, 1326–1336.
Pham, L.V., Zhou, H.J., Lin-Lee, Y.C., Tamayo, A.T., Yoshimura, L.C., Fu, L., Darnay, B.G., and Ford, R.J. (2008). Nuclear tumor necrosis factor receptor-associated factor 6 in lymphoid cells negatively regulates c-Myb-mediated transactivation through small ubiquitin-related modifier-1 modification. J Biol Chem 283, 5081–5089.
Pomerantz, J.L., Denny, E.M., and Baltimore, D. (2002). CARD11 mediates factor-specific activation of NF-kappaB by the T cell receptor complex. EMBO J 21, 5184–5194.
Rebeaud, F., Hailfinger, S., Posevitz-Fejfar, A., Tapernoux, M., Moser, R., Rueda, D., Gaide, O., Guzzardi, M., Iancu, E.M., Rufer, N., et al. (2008). The proteolytic activity of the paracaspase MALT1 is key in T cell activation. Nat Immunol 9, 272–281.
Ruefli-Brasse, A.A., French, D.M., and Dixit, V.M. (2003). Regulation of NF-kappaB-dependent lymphocyte activation and development by paracaspase. Science 302, 1581–1584.
Ruland, J., Duncan, G.S., Elia, A., del Barco Barrantes, I., Nguyen, L., Plyte, S., Millar, D.G., Bouchard, D., Wakeham, A., Ohashi, P.S., et al. (2001). Bcl10 is a positive regulator of antigen receptor-induced activation of NF-kappaB and neural tube closure. Cell 104, 33–42.
Shan, J., Zhao, W., and Gu, W. (2009). Suppression of cancer cell growth by promoting cyclin D1 degradation. Mol Cell 36, 469–476.
Shin, E.J., Shin, H.M., Nam, E., Kim, W.S., Kim, J.H., Oh, B.H., and Yun, Y. (2012). DeSUMOylating isopeptidase: a second class of SUMO protease. EMBO Rep 13, 339–346.
Stevenson, L.F., Sparks, A., Allende-Vega, N., Xirodimas, D.P., Lane, D.P., and Saville, M.K. (2007). The deubiquitinating enzyme USP2a regulates the p53 pathway by targeting Mdm2. EMBO J 26, 976–986.
Sun, L., and Chen, Z.J. (2004). The novel functions of ubiquitination in signaling. Curr Opin Cell Biol 16, 119–126.
Sun, L., Deng, L., Ea, C.K., Xia, Z.P., and Chen, Z.J. (2004). The TRAF6 ubiquitin ligase and TAK1 kinase mediate IKK activation by BCL10 and MALT1 in T lymphocytes. Mol Cell 14, 289–301.
Thome, M., and Weil, R. (2007). Post-translational modifications regulate distinct functions of CARMA1 and BCL10. Trends Immunol 28, 281–288.
Wang, D., You, Y., Case, S.M., McAllister-Lucas, L.M., Wang, L., DiStefano, P.S., Nunez, G., Bertin, J., and Lin, X. (2002). A requirement for CARMA1 in TCR-induced NF-kappa B activation. Nat Immunol 3, 830–835.
Wegener, E., Oeckinghaus, A., Papadopoulou, N., Lavitas, L., Schmidt-Supprian, M., Ferch, U., Mak, T.W., Ruland, J., Heissmeyer, V., and Krappmann, D. (2006). Essential role for IkappaB kinase beta in remodeling Carma1-Bcl10-Malt1 complexes upon T cell activation. Mol Cell 23, 13–23.
Author information
Authors and Affiliations
Corresponding author
Rights and permissions
About this article
Cite this article
Li, Y., He, X., Wang, S. et al. USP2a positively regulates TCR-induced NF-κB activation by bridging MALT1-TRAF6. Protein Cell 4, 62–70 (2013). https://doi.org/10.1007/s13238-012-2120-8
Received:
Accepted:
Published:
Issue Date:
DOI: https://doi.org/10.1007/s13238-012-2120-8